ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,098Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 461

$733K Total Retail Price of All Prescriptions

Rank: 17 out of 461

238 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 238 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

12% of this provider’s 238 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 11,249 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $101 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 664 619 1 2
WARFARIN SODIUM 494 456 2 21
SIMVASTATIN 435 411 3 3
LEVOTHYROXINE SODIUM 419 400 4 13
NAMENDA 356 343 5 69
LISINOPRIL 308 308 6 4
OMEPRAZOLE 257 256 7 8
POTASSIUM CHLORIDE 252 239 8 49
MIRTAZAPINE 252 252 8 63
ESCITALOPRAM OXALATE 250 250 10 103
DONEPEZIL HCL 242 230 11 42
SERTRALINE HCL 234 234 12 58
AMLODIPINE BESYLATE 202 187 13 1
METOPROLOL TARTRATE 200 199 14 5
ATORVASTATIN CALCIUM 190 162 15 12
LANTUS 184 163 16 62
DIVALPROEX SODIUM 161 127 17 138
SPIRONOLACTONE 139 114 18 39
GABAPENTIN 130 123 19 32
HYDROCHLOROTHIAZIDE 128 128 20 14
CARVEDILOL 125 120 21 18
CITALOPRAM HBR 122 103 22 60
IPRATROPIUM-ALBUTEROL 116 115 23 194
ADVAIR DISKUS 114 102 24 64
LEXAPRO 112 112 25 153
NOVOLOG 111 103 26 169
RISPERIDONE 109 108 27 82
OLANZAPINE 109 94 27 155
KLOR-CON M10 107 80 29 144
DIGOXIN 101 89 30 77
TAMSULOSIN HCL 94 83 31 28
HYDROCODONE-ACETAMINOPHEN 88 84 S3 32 41
LEVOFLOXACIN 84 83 33 179
AZITHROMYCIN 83 78 34 65
CEPHALEXIN 78 74 35 209
HALOPERIDOL 77 76 36 108
LANTUS SOLOSTAR 76 76 37 83
QUETIAPINE FUMARATE 75 75 38 81
METFORMIN HCL 74 74 39 17
METOPROLOL SUCCINATE 74 74 39 11
CLOPIDOGREL 74 74 39 37
GLIPIZIDE 67 67 42 66
PAROXETINE HCL 62 55 43 183
ATENOLOL 62 62 43 22
GLIPIZIDE ER 61 61 45 137
LOSARTAN POTASSIUM 60 60 46 7
EXELON 59 59 47 199
EVISTA 59 59 47 109
POLYETHYLENE GLYCOL 3350 57 36 49 106
TRAZODONE HCL 57 57 49 121
LIDODERM 55 55 51 80
METOLAZONE 54 32 52 84
PLAVIX 54 54 52 38
PREDNISONE 53 51 54 23
KLOR-CON M20 53 51 54 123
SPIRIVA 52 52 56 114
HYDROXYZINE PAMOATE 51 51 R 57 253
PANTOPRAZOLE SODIUM 50 46 58 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.